CONTRIBUTION AND EXCHANGE AGREEMENTContribution and Exchange Agreement • June 7th, 2023 • Morningside Venture Investments LTD • Biological products, (no disgnostic substances) • Delaware
SW PARENTCO, INC. SECURED CONVERTIBLE NOTE PURCHASE AGREEMENTSecured Convertible Note Purchase Agreement • June 7th, 2023 • Morningside Venture Investments LTD • Biological products, (no disgnostic substances) • Delaware
This Secured Convertible Note Purchase Agreement, dated as of May 29, 2023 (this “Agreement”), is entered into by and among SW ParentCo, Inc., a Delaware corporation (the “Company”), and the undersigned persons and entities (each an “Investor” and, collectively, the “Investors”).
JOINT FILING AGREEMENTJoint Filing Agreement • January 16th, 2020 • Morningside Venture Investments LTD • Pharmaceutical preparations
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13G to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule 13G (including amendments thereto) jointly on behalf of each such party.
Amylyx Pharmaceuticals, Inc. Lock-Up Agreement April 26, 2021Lock-Up Agreement • January 25th, 2022 • Morningside Venture Investments LTD • Pharmaceutical preparations
CONVERTIBLE INVESTMENT INSTRUMENT AGREEMENTConvertible Investment Instrument Agreement • February 14th, 2022 • Morningside Venture Investments LTD • Biological products, (no disgnostic substances) • Delaware
This Convertible Investment Instrument Agreement (“Agreement”) is dated as of December 21, 2021 by and among GreenLight Biosciences, Inc., a Delaware corporation (the “Company”) and the individuals and entities who become parties to this Agreement by executing and delivering an Agreement Signature Page in the form of Exhibit A hereto in accordance with Section 2 hereof (each a “Purchaser” and, collectively, the “Purchasers”).
JOINT FILING AGREEMENTJoint Filing Agreement • July 25th, 2023 • Morningside Venture Investments LTD • Biological products, (no disgnostic substances)
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13D amendment to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule 13D amendment (including amendments thereto) jointly on behalf of each such party.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2023 • Morningside Venture Investments LTD • Pharmaceutical preparations
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
JOINT FILING AGREEMENTJoint Filing Agreement • April 3rd, 2023 • Morningside Venture Investments LTD • Pharmaceutical preparations
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
JOINT FILING AGREEMENTJoint Filing Agreement • September 30th, 2022 • Morningside Venture Investments LTD • Pharmaceutical preparations
The undersigned, MVIL, LLC is jointly filing the attached Schedule 13D with MORNINGSIDE VENTURE INVESTMENTS LIMITED with respect to the beneficial ownership of securities of Amylyx Pharmaceuticals, Inc.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2018 • Morningside Venture Investments LTD • Pharmaceutical preparations
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13G to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule 13G (including amendments thereto) jointly on behalf of each such party.
JOINT FILING AGREEMENTJoint Filing Agreement • February 16th, 2021 • Morningside Venture Investments LTD • Pharmaceutical preparations
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
GREENLIGHT BIOSCIENCES, INC. ENVIRONMENTAL IMPACT ACQUISITION CORP.Subscription Agreement • February 14th, 2022 • Morningside Venture Investments LTD • Biological products, (no disgnostic substances)
JOINT FILING AGREEMENTJoint Filing Agreement • October 4th, 2023 • Morningside Venture Investments LTD • Pharmaceutical preparations
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2022 • Morningside Venture Investments LTD • Biological products, (no disgnostic substances)
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule 13D (including amendments thereto) jointly on behalf of each such party.
JOINT FILING AGREEMENTJoint Filing Agreement • February 16th, 2021 • Morningside Venture Investments LTD • Pharmaceutical preparations
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13G to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule 13G (including amendments thereto) jointly on behalf of each such party.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2022 • Morningside Venture Investments LTD • Pharmaceutical preparations
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13G to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule 13G (including amendments thereto) jointly on behalf of each such party.
JOINT FILING AGREEMENTJoint Filing Agreement • February 16th, 2021 • Morningside Venture Investments LTD • Pharmaceutical preparations
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13G to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule 13G (including amendments thereto) jointly on behalf of each such party.
JOINT FILING AGREEMENTJoint Filing Agreement • March 22nd, 2019 • Morningside Venture Investments LTD • Pharmaceutical preparations
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13G to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule 13G (including amendments thereto) jointly on behalf of each such party.
JOINT FILING AGREEMENTJoint Filing Agreement • August 17th, 2023 • Morningside Venture Investments LTD • Pharmaceutical preparations
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
JOINT FILING AGREEMENTJoint Filing Agreement • June 16th, 2020 • Morningside Venture Investments LTD • Pharmaceutical preparations
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
JOINT FILING AGREEMENTJoint Filing Agreement • September 20th, 2023 • Morningside Venture Investments LTD • Pharmaceutical preparations
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13G to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule 13G (including amendments thereto) jointly on behalf of each such party.
JOINT FILING AGREEMENTJoint Filing Agreement • August 17th, 2023 • Morningside Venture Investments LTD • Pharmaceutical preparations
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
JOINT FILING AGREEMENTJoint Filing Agreement • February 23rd, 2023 • Morningside Venture Investments LTD • Pharmaceutical preparations
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
JOINT FILING AGREEMENTJoint Filing Agreement • May 24th, 2019 • Morningside Venture Investments LTD • Pharmaceutical preparations
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13G to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule 13G (including amendments thereto) jointly on behalf of each such party.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2020 • Morningside Venture Investments LTD • Pharmaceutical preparations
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
JOINT FILING AGREEMENTJoint Filing Agreement • February 13th, 2018 • Morningside Venture Investments LTD • Pharmaceutical preparations
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13G to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule 13G (including amendments thereto) jointly on behalf of each such party.
JOINT FILING AGREEMENTJoint Filing Agreement • February 14th, 2022 • Morningside Venture Investments LTD • Pharmaceutical preparations
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13G to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule 13G (including amendments thereto) jointly on behalf of each such party.
JOINT FILING AGREEMENTJoint Filing Agreement • January 25th, 2022 • Morningside Venture Investments LTD • Pharmaceutical preparations
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
JOINT FILING AGREEMENTJoint Filing Agreement • March 13th, 2019 • Morningside Venture Investments LTD • Pharmaceutical preparations
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13G to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule 13G (including amendments thereto) jointly on behalf of each such party.
JOINT FILING AGREEMENTJoint Filing Agreement • November 22nd, 2021 • Morningside Venture Investments LTD • Pharmaceutical preparations
The undersigned, being duly authorized thereunder, hereby execute this agreement as an exhibit to this Schedule 13D to evidence the agreement of the below-named parties, in accordance with the rules promulgated pursuant to the Securities Exchange Act of 1934, to file this Schedule jointly on behalf of each such party.
